UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Achillion Pharmaceuticals, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Shares, $0.001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
00448Q201
--------------------------------------------------------------------------------
(CUSIP Number)
Camber Capital Management LLC, 101 Huntington Avenue, Boston, MA 02199,
617-717-6600
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 19, 2014
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
--------------------------------------------------------------------------------
CUSIP No. 00448Q201 13G Page 2 of 6 Pages
--------------------------------------------------------------------------------
1. Names of Reporting Persons.
Camber Capital Management LLC
I.R.S. Identification Nos. of above persons (entities only)
42-1693587
--------------------------------------------------------------------------------
2. Check the Appropriate Box If a Member of a Group
(See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization
Camber Capital Management LLC -- Massachusetts
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0 shares
-------------------------------------------------------------
6. SHARED VOTING POWER
NUMBER OF
SHARES 5,700,000 shares
BENEFICIALLY -------------------------------------------------------------
OWNED BY EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 0 shares
-------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
5,700,000 shares
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
Camber Capital Management LLC -- 5,700,000 shares
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) |_|
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
Camber Capital Management LLC -- 5.89%
--------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
Camber Capital Management LLC -- 00 (Limited Liability Company)
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
CUSIP No. 00448Q201 13G Page 3 of 6 Pages
--------------------------------------------------------------------------------
1. Names of Reporting Persons.
Stephen DuBois
I.R.S. Identification Nos. of above persons (entities only)
N/A
--------------------------------------------------------------------------------
2. Check the Appropriate Box If a Member of a Group
(See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization
Stephen DuBois -- United States
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
0 shares
-------------------------------------------------------------
6. SHARED VOTING POWER
NUMBER OF
SHARES 5,700,000 shares
BENEFICIALLY -------------------------------------------------------------
OWNED BY EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 0 shares
-------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
5,700,000 shares
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
Stephen DuBois -- 5,700,000 shares
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) |_|
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
Stephen DuBois -- 5.89%
--------------------------------------------------------------------------------
12. Type of Reporting Person (See Instructions)
Stephen DuBois -- IN
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
CUSIP No. 00448Q201 13G Page 4 of 6 Pages
Item 1.
(a) Name of Issuer:
Achillion Pharmaceuticals, Inc.
(b) Address of Issuer's Principal Executive Offices:
300 George Street, New Haven, CT 06511
Item 2.
(a) Name of Person Filing:
Camber Capital Management LLC
Stephen DuBois
(b) Address of the Principal Office or, if none, residence:
Camber Capital Management LLC
Stephen DuBois
101 Huntington Avenue
Suite 2550
Boston, MA 02199
(c) Citizenship:
Camber Capital Management -- Massachusetts
Stephen DuBois -- United States
(d) Title of Class of Securities:
Common Shares, $0.001 par value (the "Common Shares")
(e) CUSIP Number:
00448Q201
Item 3. If this statement is filed pursuant to SS.240.13d-1(b) or 240.13d-2(b)
or (c), check whether the person filing is a:
(a) |_| Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o).
(b) |_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) |_| Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) |_| Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C 80a-8).
(e) | | An investment adviser in accordance with S.240.13d-1(b)(1)(ii)(E);
(f) |_| An employee benefit plan or endowment fund in accordance with
S.240.13d-1(b)(1)(ii)(F);
(g) |_| A parent holding company or control person in accordance with
S. 240.13d-1(b)(1)(ii)(G);
(h) |_| A savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
(i) |_| A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of
1940 (15 U.S.C. 80a-3);
(j) |_| Group, in accordance with S.240.13d-1(b)(1)(ii)(J).
Item 4. Ownership
Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: Camber Capital Management LLC -- 5,700,000
Stephen DuBois -- 5,700,000
(b) Percent of class: Camber Capital Management LLC -- 5.89%
Stephen DuBois -- 5.89%
--------------------------------------------------------------------------------
CUSIP No. 00448Q201 13G Page 5 of 6 Pages
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote
Camber Capital Management LLC -- 0
Stephen DuBois -- 0
(ii) Shared power to vote or to direct the vote
Camber Capital Management LLC -- 5,700,000
Stephen DuBois -- 5,700,000
(iii) Sole power to dispose or to direct the disposition
of
Camber Capital Management LLC-- 0
Stephen DuBois -- 0.
(iiii) Shared power to dispose or to direct the disposition
of
Camber Capital Management LLC-- 5,700,000
Stephen DuBois -- 5,700,000
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following | |.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company or Control Person.
Item 8. Identification and Classification of Members of the Group
Item 9. Notice of Dissolution of Group
Item 10. Certification
(b) The following certification shall be included if the statement is
filed pursuant to S.240.13d-1(c):
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
CAMBER CAPITAL MANAGEMENT LLC
By: /s/Sean George
Sean George
Chief Financial Officer
STEPHEN DUBOIS
By: /s/ Stephen DuBois
Stephen DuBois, individually
--------------------------------------------------------------------------------
CUSIP No. 928645100 13G Page 6 of 6 Pages
JOINT FILING AGREEMENT
This Joint Filing Agreement, dated May 29, 2014, is by and between Camber
Capital Management LLC, a Massachusetts limited liability company, and Stephen
DuBois, an individual (the foregoing are collectively referred to herein as the
"Filers").Each of the Filers may be required to file with the United States
Securities and Exchange Commission a statement on Schedule 13G with respect to
common shares, $0.001 par value of Achillion Pharmaceuticals, Inc. beneficially
ownned by them from time to time. Pursuant to and in accordance with Rule 13(d)
(1)(k) promulgated under the Securities Exchange Act of 1934, the Filers
hereby agree to file a single statement on Schedule 13G and/or 13D (and any
amendments thereto) on behalf of each of such parties, and hereby further agree
to file this Joint Filing Agreement as an exhibit to such statement, as required
by such rule. This Joint Filing Agreement may be terminated by any of the Filers
upon one week's prior written notice or such lesser period of notice as the
Filers may mutually agree.
Executed and delivered as of the date first above written.
CAMBER CAPITAL MANAGEMENT LLC
By: /s/ Sean George
Sean George
Chief Financial Officer
STEPHEN DUBOIS
By: /s/ Stephen DuBois
Stephen DuBois, individually